10:30 AM EDT, 07/31/2024 (MT Newswires) -- Avanos Medical's ( AVNS ) shares advanced 5% during Wednesday trading after reporting Q2 adjusted earnings of $0.34 per diluted share compared with $0.24 a year earlier.

Three analysts polled by Capital IQ expected $0.29.

Net sales for the quarter ended June 30 was $171.7 million, compared with $169.4 million a year earlier.

Three analysts surveyed by Capital IQ expected $170.7 million.

For 2024, the health care technology company is projecting adjusted earnings of $1.30 to $1.45 per diluted share on revenue of between $685 million and $705 million.

Three analysts polled by Capital IQ expect adjusted earnings of $1.38 per diluted share on revenue of $695.4 million.

Price: 24.12, Change: +1.16, Percent Change: +5.05